Stillbirth · pregnant women giving birth in non‐facility settings
Prophylactic oxytocin injection (delivered by community health… showed no clear difference in stillbirths [ compared with control (no injection) (low certainty).
1 finding from 1 review
Early infant death (0‐3 days) [ · pregnant women giving birth in non‐facility settings
Prophylactic oxytocin injection (delivered by community health… showed no clear difference in early infant death (0‐3 days) [ compared with control (no injection) (low certainty).
1 finding from 1 review
Use of oxytocin ‐ not reported · breech presentation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Use of oxytocin · breech presentation
Summary of findings table ‐ Moxibustion plus usual care probably leads to lower use of oxytocin compared with usual care (moderate certainty).
1 finding from 1 review
Oxytocin augmentation · women in the third trimester for induction of labour.
It is very uncertain whether oral misoprostol changes oxytocin augmentation compared with vaginal dinoprostone (very low certainty).
1 finding from 1 review
Oxytocin augmentation · women in the third trimester for induction of labour.
Oral misoprostol may leads to higher oxytocin augmentation compared with vaginal misoprostol (low certainty).
1 finding from 1 review
Oxytocin augmentation · women in the third trimester for induction of labour.
Oral misoprostol may leads to lower oxytocin augmentation compared with mechanical methods (low certainty).
1 finding from 1 review
Oxytocin augmentation · women in the third trimester for induction of labour with intact membranes
It is very uncertain whether oral misoprostol one‐ to two‐hourly changes oxytocin augmentation compared with oral misoprostol four‐ to six‐hourly (very low certainty).
1 finding from 1 review
Oxytocin augmentation · women with ruptured membranes in the third trimester for induction of labour.
Oral misoprostol probably leads to lower oxytocin augmentation compared with placebo/no treatment (moderate certainty).
1 finding from 1 review
Oxytocin augmentation · induction of labour.
It is very uncertain whether oral misoprostol 20 µg hourly titrated changes oxytocin augmentation compared with oral misoprostol 25 µg two‐hourly static (very low certainty).
1 finding from 1 review
Oxytocin augmentation · women in spontaneous labour at term
Partograph showed no clear difference in oxytocin augmentation compared with no partograph (studies carried out (moderate certainty).
1 finding from 1 review
Severe PPH (≥ 1000 mL) · women in the 3rd stage of labour undergoing a vaginal birth.
Intravenous showed no clear difference in severe PPH ≥ 1000 mL compared with intramuscular oxytocin (moderate certainty).
1 finding from 1 review
Serious maternal morbidity · women in the 3rd stage of labour undergoing a vaginal birth.
Intravenous showed no clear difference in serious maternal morbidity compared with intramuscular oxytocin (moderate certainty).
1 finding from 1 review
Maternal death · women in the 3rd stage of labour undergoing a vaginal birth.
1 finding from 1 review
Frequency of PPH ≥ 500 mL · women in the 3rd stage of labour undergoing a vaginal birth.
Intravenous leads to lower PPH ≥ 500 mL compared with intramuscular oxytocin (high certainty).
1 finding from 1 review
Use of additional uterotonics · women in the 3rd stage of labour undergoing a vaginal birth.
Intravenous showed no clear difference in use of additional uterotonics compared with intramuscular oxytocin (low certainty).
1 finding from 1 review
Blood transfusion · women in the 3rd stage of labour undergoing a vaginal birth.
Intravenous leads to lower blood transfusion compared with intramuscular oxytocin (high certainty).
1 finding from 1 review
Hypotension · women in the 3rd stage of labour undergoing a vaginal birth.
Intravenous showed no clear difference in hypotension compared with intramuscular oxytocin (moderate certainty).
1 finding from 1 review
Vaginal birth within 24 hours · women in the third trimester for induction of labour.
Oral misoprostol showed no clear difference in vaginal birth within 24 hours compared with intravenous oxytocin (low certainty).
1 finding from 1 review
Caesarean section · women in the third trimester for induction of labour.
Oral misoprostol probably leads to lower caesarean section compared with intravenous oxytocin (moderate certainty).
1 finding from 1 review